Estelle S. Harris

5.2k citations
23 papers · 1.8k indexed · h-index 18

Estelle S. Harris

22 papers receiving 1.8k citations

Peers

Estelle S. Harris
Comparison fields: 5 of 96
  • Immunology and Allergy 372
  • Immunology 1000
  • Hematology 358
  • Internal Medicine 56
  • Oncology 269
Replace Erin F. McAvoy with:
Erin F. McAvoy Canada
Gary Sinclair Canada
Birgitta Gullstrand Sweden
Gerard R. Majeau United States
E R de Groot Netherlands
J A Hoxie United States
Stavros Giaglis Switzerland
Agostina Carestia Argentina
Grace M. Thomas United States
Omri Snir Norway
Estelle S. Harris relative to Erin F. McAvoy Canada Erin F. McAvoy's profile →
Citations per field
00.5×1.5×
Erin F. McAvoy · 1×
Citations per year

Countries citing papers authored by Estelle S. Harris

Since Specialization
Citations

This map shows the geographic impact of Estelle S. Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Estelle S. Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Estelle S. Harris more than expected).

Fields of papers citing papers by Estelle S. Harris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Estelle S. Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Estelle S. Harris. The network helps show where Estelle S. Harris may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Estelle S. Harris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Estelle S. Harris Line = papers co-authored together Estelle S. Harris links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 202210
3 202020
4 202021
5 2019122
6 2016119
7 201463
8 201433
9 201296
10 201265
11 201118
12 2011112
13 201116
14 200820
15 2002124
16 200182
17 2000242
18 199836
19 199616
20 1993274

About Estelle S. Harris

Estelle S. Harris is a scholar working on Immunology and Allergy, Hematology and Immunology, having authored 23 papers that have together received 1.8k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (10 papers), Cell Adhesion Molecules Research (10 papers), Immune Response and Inflammation (5 papers), Sepsis Diagnosis and Treatment (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), COVID-19 Clinical Research Studies (3 papers), Blood disorders and treatments (3 papers) and Pneumonia and Respiratory Infections (2 papers). The work is most often cited by research in Immunology and Allergy (372 citations), Immunology (1000 citations) and Hematology (358 citations). Estelle S. Harris has collaborated with scholars based in United States, India and Brazil. Frequent co-authors include Guy A. Zimmerman, Andrew S. Weyrich, Thomas M. McIntyre, Stephen M. Prescott, Matthew T. Rondina, Colin K. Grissom, Mark J. Cody, Christian C. Yost, Hansjörg Schwertz and Pamela J. Reynolds. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026